It's true — Nissan will be dropping the Altima midsize sedan after the 2026 model year. The reason why Nissan is doing this is that the company is adjusting its lineup to better meet the demands of ...
Thieves in Milwaukee are using new technology to steal cars with key fobs and push-start ignitions. The criminals use key fob programmers or signal interceptors to gain access to vehicles. A Milwaukee ...
Nissan’s Altima was one of a couple of sedans that saw sales down in the second quarter of 2026. The decline isn’t from a lack of customer interest, however. The Altima is actually selling, with the ...
The Nissan Altima is taking one more victory lap before riding into the sunset after the 2027 model year. Car and Driver reports that a Nissan executive has confirmed that the once-popular midsize ...
Yesterday, we brought you news that the Nissan Altima has been cancelled. Today we're bringing you news that while we still expect the Altima to find itself on the wrong side of survival, Nissan says ...
Alina has been enthusiastic about vehicles her entire life, and even from an early age found herself itching to get behind the wheel. Through high school and college, she could be found reading ...
It took a bit more time than many anticipated, but the day has finally arrived: The Nissan Altima is dead. The news was confirmed by the company’s Senior VP and Chief Product & Planning Officer for ...
Nissan is finally killing the Altima sedan, based on what Ponz Pandikuthira, head of product planning in North America, told WardsAuto. The executive reportedly said the Altima is being killed to give ...
Earlier this year, Nissan announced plans to kill off 11 different models as part of their “Mobility Intelligence for Everyday Life” strategy. At the time, the company was coy on specifics but said ...
Nissan Altimas are known to have above-average reliability, but an extended warranty might be worthwhile for long-term ownership or high-mileage driving. We’ll break down what a Nissan Altima warranty ...
Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results